TriplePoint Venture Growth BDC Corp. announced that certain investment funds managed by Goldman Sachs Asset Management purchased 1,594,007 shares of TPVG’s common stock in a private placement transaction at a purchase price of $13.54 per share, resulting in approximately $21.6 million of net proceeds. In addition, Goldman Sachs has agreed to purchase up to an additional 200,000 shares of TPVG’s common stock immediately following the additional issuance of shares of TPVG’s common stock in a registered offering or private placement. Continue reading “TriplePoint Venture Growth Gets $22 Million Investment From Goldman Sachs”
Assured Guaranty looks like an awesome oversold setup on the chart with MKM Partners giving the stock a Buy rating on October 5, 2017.
Assured Guaranty provides credit protection products to the United States and international public finance, including infrastructure, and structured finance markets. It applies its credit underwriting judgment, risk management skills and capital markets experience primarily to offer financial guaranty insurance that protects holders of debt instruments and other monetary obligations from defaults in scheduled payments. Continue reading “Assured Guaranty Oversold, Gets Buy Rating From MKM Partners”
The Dodd Frank Wall Street Reform and Consumer Protection Act took a hit this week after the House passes a bill that guts many parts.
The House passed a bill called the Financial Choice Act that would allow banks to opt out of some regulations if they hold enough capital and would repeal the Volcker rule that barred banks from speculative trading.
One key component of the bill that I like is that banks will no longer be bailed out with tax payers funds as they will be forced to go through bankruptcy like any other industry.
Repeal the Dodd Frank Wall Street Reform and Consumer Protection Act
President Trump promised to repeal the Dodd Frank Wall Street Reform and Consumer Protection Act because it’s bad for business and in particular for small banks.
One of the original authors of the legislation, Jeb Hensarling (Republican from Texas) said Dodd Frank is a major factor in limiting GDP growth in the wake of the financial crisis.
Banking stocks are surging higher on news of the House bill but most see little chance of it passing in the Senate. Still, stock traders figure that even a watered down Senate version is better than what we currently have.
In an economic news report posted on YouTube (link above) by X22 Report, it cites how the average Millennial has less than $1,000 saved to buy a home. Not only do I think that’s true, I would add that the average Millennial has zero money saved for retirement.
Economic News Forecasts Recession
Most younger people have low paying service sector jobs like McDonald’s or Carl’s Junior, and most are dealing with student loan debt.
X22 Report says that the economy has already entered into a recession and is on the verge of a complete collapse.
Please keep in mind that the X22 Report is a perma-bear YouTube channel and they make money off of doomsday preppers and pitching gold and silver. They operate in the alternative news niche and so understand the alternative news industry. Don’t go bipolar and go out and short the market just yet. Nevertheless, it’s good to listen to the bearish perspective to balance against the bull perspective of the mainstream financial media.
A weekly Saturday night financial show that attempts to predict market direction for the week ahead by looking at a variety of technical and fundamental indicators. This week’s show includes commentary on the Fed’s first and only rate hike in 2016, Eli Lilly’s long-acting Basal Insulin that’s now available in the US, takeover rumors circulating about Qorvo, Protalix Biotherapeutics $24 million order to treat Gaucher patients in Brazil, the FDA approval of Vericel’s Maci for the repair of cartilage defects of the knee, Silicon Motion’s supplying of SSD solutions to the Alibaba Group, and more.
Pharmaceutical drug pricing is all over the mainstream financial media right now. Let’s examine the macroeconomics of what is happening.
The demand for pharmaceutical drugs is inelastic. People that need a pharmaceutical drug prescribed by their doctor will demand that drug regardless of price. As the price of the drug goes up, demand mostly stays the same. Continue reading “Pharmaceutical Drug Pricing”